Mantle cell lymphoma | Lymphoma, Follicular | Diffuse Large B-Cell Lymphoma
Item
1. patient has a histologically confirmed diagnosis of mantle cell lymphoma, follicular lymphoma, or diffuse large b cell lymphoma.
boolean
C0334634 (UMLS CUI [1])
C0024301 (UMLS CUI [2])
C0079744 (UMLS CUI [3])
Recurrent disease | Refractory Disease | Prior Therapy Quantity
Item
2. patient has relapsed or refractory disease and received at least one prior therapy.
boolean
C0277556 (UMLS CUI [1])
C1514815 (UMLS CUI [2])
C1514463 (UMLS CUI [3,1])
C1265611 (UMLS CUI [3,2])
Diffuse Large B-Cell Lymphoma | Autologous hematopoietic stem cell transplant | Allogeneic hematopoietic stem cell transplant | Patient Ineligible Autologous hematopoietic stem cell transplant | Patient Ineligible Allogeneic hematopoietic stem cell transplant
Item
3. patient with diffuse large b cell lymphoma has received or is ineligible for autologous or allogeneic stem cell transplant.
boolean
C0079744 (UMLS CUI [1])
C2193200 (UMLS CUI [2])
C4255274 (UMLS CUI [3])
C0030705 (UMLS CUI [4,1])
C1512714 (UMLS CUI [4,2])
C2193200 (UMLS CUI [4,3])
C0030705 (UMLS CUI [5,1])
C1512714 (UMLS CUI [5,2])
C4255274 (UMLS CUI [5,3])
Lesion nodal Quantity | Measurable lesion nodal Size | Measurable lesion Extranodal Quantity
Item
4. patient has at least one measurable nodal lesion (≥2 cm) according to cheson criteria (cheson 2007). in case where the patient has no measurable nodal lesions ≥ 2 cm in the long axis at baseline, then the patient must have at least one measurable extra-nodal lesion.
boolean
C0221198 (UMLS CUI [1,1])
C0443268 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
C1513041 (UMLS CUI [2,1])
C0443268 (UMLS CUI [2,2])
C0456389 (UMLS CUI [2,3])
C1513041 (UMLS CUI [3,1])
C1517067 (UMLS CUI [3,2])
C1265611 (UMLS CUI [3,3])
ECOG performance status
Item
5. patient has an eastern cooperative oncology group (ecog) performance status ≤ 2.
boolean
C1520224 (UMLS CUI [1])
Bone Marrow function | Organ function
Item
6. patient has adequate bone marrow and organ function.
boolean
C0005953 (UMLS CUI [1,1])
C0031843 (UMLS CUI [1,2])
C0678852 (UMLS CUI [2])
PI3K inhibitor
Item
1. patient has received previous treatment with pi3k inhibitors
boolean
C1519050 (UMLS CUI [1])
Graft-vs-Host Disease
Item
2. patient has evidence of graft versus host disease (gvhd).
boolean
C0018133 (UMLS CUI [1])
CNS disorder
Item
3. patient has active or history of central nervous system (cns) disease.
boolean
C0007682 (UMLS CUI [1])
Cancer Other | Exception Basal cell carcinoma Treated | Exception Squamous cell carcinoma of skin Treated | Exception Skin carcinoma Treated
Item
4. patient has a concurrent malignancy or has a malignancy within 3 years of study enrollment (with the exception of adequately treated basal or squamous cell carcinoma or non-melanomatous skin cancer).
boolean
C1707251 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0007117 (UMLS CUI [2,2])
C1522326 (UMLS CUI [2,3])
C1705847 (UMLS CUI [3,1])
C0553723 (UMLS CUI [3,2])
C1522326 (UMLS CUI [3,3])
C1705847 (UMLS CUI [4,1])
C0699893 (UMLS CUI [4,2])
C1522326 (UMLS CUI [4,3])
Patient Health Questionnaire - 9 Item
Item
5. patient has a score ≥ 12 on the phq-9 questionnaire.
boolean
C4083201 (UMLS CUI [1])
GAD-7
Item
6. patient has a gad-7 mood scale score ≥ 15.
boolean
C3641330 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
7. pregnant or nursing women
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Contraceptive methods Absent
Item
8. patient who does not use highly effective contraception methods to avoid becoming pregnant or conceiving offspring.
boolean
C0700589 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
Eligibility Criteria Study Protocol
Item
other protocol-defined inclusion/exclusion criteria may apply.
boolean
C1516637 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])